Explore how ELISA systems detect SARS-CoV-2 antibodies, their development process, and applications in COVID-19 pandemic management.
Discover how SNHG15, a long non-coding RNA, acts as a double agent helping SARS-CoV-2 enter cells through the RABL2A-ACE2 pathway.
Explore how scientists design and synthesize isatin derivatives to inhibit SARS-CoV-2 3CL protease, a key target for COVID-19 therapeutics.
Exploring how Serine 477 in SARS-CoV-2 spike protein regulates viral infection through ACE2 interaction and its implications for treatments.